Loading...

    Submit Your PaperJournalsTrack Article StatusAPC
    AB Journals logo

    An international journal platform supporting research and innovation by making knowledge accessible to everyone, everywhere.

    15442 Ventura Blvd., Ste 201-1717, Sherman Oaks, California, 91403, USA.
    +1 (213) 371-4405
    WhatsApp: +1 (313) 787-3690
    XFacebookLinkedInInstagramYoutube

    Get Journal Updates

    Stay informed about newly published articles, latest issues, and announcements from your selected journals.

    Select Journals

    Receive updates by email. Unsubscribe at any time.

    For Authors

    • Submit Your Paper
    • Track Article Status
    • Editorial Process
    • Guidelines Hub
    • Manuscript Requirements
    • Submission Guidelines
    • Article Processing Charges
    • Pay APC
    • Open Access Policy
    • Waiver Policy

    Journal Subject

    • Management Sciences
    • Humanities & Social Sciences
    • Education
    • Sciences
    • Engineering

    About

    • About AB Journal
    • Policies & Ethics
    • Contact Us
    • Feedback
    • FAQs
    • Terms
    • Privacy Policy

    Resources

    • For Reviewers
    • For Editors
    • For Authors
    • Why Publish With Us

    Copyright © 2026 AB Journals. All rights reserved.

    Open Access
    AB Journals logo
    1. Home
    2. Search Results
    Submit Your PaperJournalsTrack Article StatusAPC

    Showing 2 results found

    Keywords
    Article
    Advanced Breast Cancer in Nigeria: A Single Centre Experience
    Wichendu P.N., Dodiyi-Manuel A.
    May 17, 2021•DOI: 10.52589/AJBMR-T1CPAEN•Volume 4 Issue 2•2,256 views
    Background: Breast cancer is the most common cancer globally and in Nigeria, it constitutes about 12% of all new cancers and 25% of all cancers in women. In Nigeria, the majority of patients present with late disease and globally, advanced breast cancer is associated with a low survival rate among patients. This study seeks to review the presentation of advanced breast cancer as seen in the University of Port Harcourt Teaching Hospital, Southern Nigeria. Patients and Methods: This is a 5-year retrospective study conducted at the University of Port Harcourt Teaching Hospital. Records of patients that presented to the hospital within the study period with histologically proven breast cancer (stages 3 and 4) were retrieved, and relevant data extracted and analysed using SPSS version 22. Results: There were 47 patients with advanced breast cancer and they were all females. Their ages ranged from 25 to 72 years with a mean of 43.9 ± 4.7 and peak age of 31–50 years. Majority of the patients (72.3%) had stage 3 disease while 13 (27.7%) of them had stage 4. The lung was the commonest metastatic site and this was seen in 7 (14.9%) patients, followed by the liver in 1 (2.1%). Conclusion: Advanced breast cancer remains a dreaded disease that reduces patients’ quality of life significantly and may also be rapidly fatal. Community-based efforts in collaboration with Non-Governmental Organizations (NGOs) targeted at information dissemination to the public, and offering breast cancer screening and subsidized cancer treatment are essential to reduce the mortality associated with this deadly disease. Read more
    Keywords:Presentationadvanced breast cancerUniversity of Port Harcourt Teaching Hospital.
    Journal
    Journal of Microbiology and Applied Biotechnology

    Journal of Microbiology and Applied Biotechnology (JMAB) is an international peer-reviewed open access journal that publishes original research in microbiology, biotechnology, microbial sciences, and related life science disciplines. The journal provides a platform for the dissemination of high-quality theoretical, experimental, and applied research that advances understanding of microorganisms and their applications in health, agriculture, industry, food systems, and environmental sustainability. JMAB welcomes contributions that explore microbial diversity, biological processes, and biotechnological innovations that address scientific, industrial, and societal challenges.